Second-line chemotherapy for advanced or recurrent endometrial carcinoma previously treated with paclitaxel and carboplatin, with or without epirubicin
about
Second-line chemotherapy for advanced or recurrent endometrial carcinoma previously treated with paclitaxel and carboplatin, with or without epirubicin
description
2010 nî lūn-bûn
@nan
2010 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
name
Second-line chemotherapy for a ...... in, with or without epirubicin
@ast
Second-line chemotherapy for a ...... in, with or without epirubicin
@en
Second-line chemotherapy for a ...... in, with or without epirubicin
@nl
type
label
Second-line chemotherapy for a ...... in, with or without epirubicin
@ast
Second-line chemotherapy for a ...... in, with or without epirubicin
@en
Second-line chemotherapy for a ...... in, with or without epirubicin
@nl
prefLabel
Second-line chemotherapy for a ...... in, with or without epirubicin
@ast
Second-line chemotherapy for a ...... in, with or without epirubicin
@en
Second-line chemotherapy for a ...... in, with or without epirubicin
@nl
P2093
P2860
P1476
Second-line chemotherapy for a ...... in, with or without epirubicin
@en
P2093
Kiyoshi Yoshino
Masami Fujita
Tadashi Kimura
Takahito Miyake
Takashi Miyatake
Takayuki Enomoto
Takuhei Yokoyama
Tomomi Egawa-Takata
Yutaka Ueda
P2860
P2888
P304
P356
10.1007/S00280-010-1384-Z
P577
2010-06-20T00:00:00Z
P5875
P6179
1004686748